Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02848313
Recruitment Status : Unknown
Verified September 2017 by Stealth BioTherapeutics Inc..
Recruitment status was:  Active, not recruiting
First Posted : July 28, 2016
Last Update Posted : September 6, 2017
Sponsor:
Information provided by (Responsible Party):
Stealth BioTherapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2018
Estimated Study Completion Date : March 2018